On March 5, 2019 the Food and Drug Administration (FDA) approved the first truly new medication for major depression in decades. The drug is a nasal spray called esketamine, derived from ketamine—an anesthetic that has made waves for its surprising antidepressant effect. Interestingly, studies from Yale research labs showed that the drug ketamine, which was widely used as …
You might be familiar with ketamine, a drug commonly used for its anesthetic properties in emergency rooms, however, is now rapidly gaining recognition due to its swift alleviation of depression, anxiety, and even post-traumatic stress disorder (PTSD). Ketamine has recently garnered widespread attention for its potential to treat various mental health conditions that are often …
Welcome back to Doctor in the dugout. I’m your host, Dr. Alan Beyer, and I’m thrilled to be joined today by phone with our special guest, Ben Spielberg, the CEO and founder of Bespoke Treatment. Ben, thanks so much for being with us today. Of course, I’m happy to be here. So, first of all, …
Bespoke Treatment focuses on non-medication treatments that last. We are the first boutique center in Southern California to specialize in personalized TMS therapy, Ketamine treatment, and neurofeedback.
